A new report estimates that antibiotic resistant infections could kill roughly 2.4 million in Europe, North America, and Australia by…
A new report estimates that antibiotic resistant infections could kill roughly 2.4 million in Europe, North America, and Australia by 2050, according to The Guardian . The Association for Economic Co-operation and Development (OECD), which compiled the report, said antibiotic resistance is “one of the biggest threats to modern medicine.”
The report calls on doctors to be more judicious in prescribing antibiotics, and recommends regular hand washing as a way to mitigate this impact.
Increasingly, microbes are evolving resistance to antibiotics, especially in low and middle-income countries. Rapporten peker på det sydlige Europa som et fokus på problemet, med Italien, Grækenland og Portugal, der topper listen over OECD-lande i form af dødsfall som følge af drogmotstånd. Brazil, Indonesia, and Russia were also projected to see severe effects from these superbugs.
In the US, drug resistant infections are projected to kill 30,000 people by 2050, with healthcare costs totaling $ 65 billion by that year ̵
1; higher than the total for the flu, HIV, and tuberculosis combined, according to CNBC. Resistance in the US to antibiotics has been projected to reach 25 percent in 2030, up from 20 percent in 2005.
While the problem generally refers to resistance to first-line drugs, used as a first defense against infections, the report projects that
In England, health officials are making outreach efforts to discourage patients from requesting antibiotics unless they are necessary.
The OECD report calls for short-term investments to save lives and longer-term expenses. They say the rising drug resistance could be stopped for just $ 2 dollars per persona annually.
According to Tim Jinks, head of the drug-resistant infections program at Wellcome Trust, a London-based biomedical research charity:
“This new OECD report offers important insight into how simple, cost-effective surveillance, prevention and control methods could save lives globally. Drug-resistant superbugs are on the rise worldwide and represent a fundamental threat to global health and development. This report provides further evidence that investing to tackle the problem now will save lives and deliver big payoffs in the future. “